论文信息 - Combination Therapy With Pulmonary Vasodilatation and JAK2 Inhibition for Pulmonary Hypertension With Polycythemia Vera - 字舞流文

Combination Therapy With Pulmonary Vasodilatation and JAK2 Inhibition for Pulmonary Hypertension With Polycythemia Vera

A. Goda | T. Satoh | T. Kohno | K. Takeuchi | H. Kikuchi | T. Inami | N. Takayama | Kyoko Soejima | Riichi Momose

[1] Xiaofeng Wang,et al. Evaluation of hemodynamic parameters among patients with myeloproliferative neoplasms and suspected pulmonary hypertension , 2021, Leukemia & lymphoma.

[2] R. Devereux,et al. Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3] H. Nakajima,et al. Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera , 2017, Internal medicine.

[4] S. Harari,et al. Pulmonary hypertension in patients with chronic myeloproliferative disorders , 2015, European Respiratory Review.

[5] L. Zhang,et al. Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis , 2014, Leukemia.